Our novel exploratory analyses of T-cell function show a significant improvement in IFNγ production from CD4+ and CD8+ T-cells towards the tumor associated antigen MAGE-A4, and a non-significant trend for MAGE-A3 suggesting that T-cells post-intervention are more capable of recognizing tumor antigens. The gene discussed is CD8A; the disease is neoplasm.